Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: Results from a Randomized, Open Label, Crossover Study

被引：0
|
作者：
Belén Sádaba
Jose Ramón Azanza
Aintzane García-Bea
Luis Labeaga
Cristina Campo
Román Valiente
机构：
[1] Clínica Universidad de Navarra,Clinical Pharmacology Service
[2] IdiSNA,Medical Department
[3] Navarra Institute for health Research,Clinical Research Department
[4] Faes Farma S. A.,undefined
[5] Faes Farma S. A.,undefined
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2020年 / 45卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：265 / 272
页数：7
相关论文
共 50 条
  • [11] Piroxicam Immediate Release Formulations: A Fasting Randomized Open-Label Crossover Bioequivalence Study in Healthy Volunteers
    Helmy, Sally A.
    EL-Bedaiwy, Heba M.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (06): : 466 - 471
  • [12] Pharmacokinetic bioequivalence of sitagliptin phosphate tablet formulations: a randomized, open-label, crossover study in healthy volunteers
    Leong, Chuei Wuei
    Sagim, Elton
    Yee, Kar Ming
    Saharuddin, Muhammad Shalhadi
    Abdullah, Nik Mohd Zulhakimi Nik
    Saberi, Noramirah Farhanah
    Boopathy, Rajavikraman
    Ahmad, Shahnun
    Amran, Atiqah
    Batheja, Raman
    Sharma, Rajan
    Vuppalavanchu, Kiran Kumar
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2023, 12 (01):
  • [13] Metronidazole Immediate Release Formulations: A Fasting Randomized Open-Label Crossover Bioequivalence Study in Healthy Volunteers
    de Freitas Silva, M.
    Schramm, S. G.
    Kano, E. K.
    Koono, E. E. M.
    Manfio, J. L.
    Porta, V.
    dos Reis Serra, C. H.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 (10): : 490 - 495
  • [14] A randomized, open-label study assessing the bioequivalence of two formulations of Fingolimod 0.5 mg in healthy subjects
    Mario Tanguay
    Thomas Fröhlich
    Mathieu Drouin
    Gerald Beuerle
    AAPS Open, 4 (1)
  • [15] Comparative study on the bioequivalence of two formulations of pravastatin - Data from a crossover, randomised, open-label bioequivalence study in healthy volunteers
    Almeida, S
    Filipe, A
    Almeida, A
    Gich, I
    Antonijoan, R
    Puntes, M
    Barbanoj, M
    Caturla, MC
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2006, 56 (02): : 70 - 75
  • [16] Levocetirizine Oral Disintegrating Tablet: A Randomized Open-Label Crossover Bioequivalence Study in Healthy Japanese Volunteers
    Ino, Hiroko
    Shiramoto, Masanari
    Eto, Takashi
    Haranaka, Miwa
    Irie, Shin
    Terao, Takumi
    Ogura, Hirofumi
    Wakamatsu, Akira
    Hoyano, Keiko
    Nakano, Atsushi
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (07): : 805 - 812
  • [17] A randomized, open-label, 2-period, crossover bioequivalence study of two oral formulations of 75 mg oseltamivir in healthy Thai volunteers
    Kongpatanakul, S.
    Chatsiricharoenkul, S.
    Panich, U.
    Sathirakul, K.
    Pongnarin, P.
    Sangvanich, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (12) : 654 - 662
  • [18] Pharmacokinetics and Bioequivalence Evaluation of Erlotinib Hydrochloride Tablets: Randomized, Open-Label, 2-Period Crossover Study in Healthy Chinese Subjects
    Wang, Lu
    Ruan, Zourong
    Yang, Dandan
    Hu, Yin
    Liang, Jian
    Chen, Jinliang
    Shao, Rong
    Xu, Yichao
    Guan, Yanlu
    Jiang, Bo
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (02): : 166 - 172
  • [19] Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediateand extended-release formulations in healthy subjects
    Marier, Jean-Francois
    Ducharme, Murray P.
    DiMarco, Marika
    Di Spirito, Mike
    Morelli, Gaetano
    Tippabhotla, Sudhakar K.
    Badri, N.
    Rampal, Ashok
    Monif, Tausif
    CLINICAL THERAPEUTICS, 2006, 28 (12) : 2070 - 2080
  • [20] Bioequivalence Evaluation of Single Doses of Two Tramadol Formulations: A Randomized, Open-Label, Two-Period Crossover Study in Healthy Brazilian Volunteers
    Silva, Marina de Freitas
    Schramm, Simone Grigoleto
    Kano, Eunice Kazue
    Mori Koono, Eunice Emiko
    Porta, Valentina
    dos Reis Serra, Cristina Helena
    CLINICAL THERAPEUTICS, 2010, 32 (04) : 758 - 765
12345